277 related articles for article (PubMed ID: 16352808)
1. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
Zhang C; Todorov I; Zhang Z; Liu Y; Kandeel F; Forman S; Strober S; Zeng D
Blood; 2006 Apr; 107(7):2993-3001. PubMed ID: 16352808
[TBL] [Abstract][Full Text] [Related]
2. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
[TBL] [Abstract][Full Text] [Related]
3. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
5. In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease.
Zhao D; Zhang C; Yi T; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
Blood; 2008 Sep; 112(5):2129-38. PubMed ID: 18550852
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
[TBL] [Abstract][Full Text] [Related]
7. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
[TBL] [Abstract][Full Text] [Related]
8. Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.
Young JS; Wu T; Chen Y; Zhao D; Liu H; Yi T; Johnston H; Racine J; Li X; Wang A; Todorov I; Zeng D
J Immunol; 2012 Jul; 189(1):222-33. PubMed ID: 22649197
[TBL] [Abstract][Full Text] [Related]
9. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
10. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.
Hanash AM; Levy RB
Blood; 2005 Feb; 105(4):1828-36. PubMed ID: 15494429
[TBL] [Abstract][Full Text] [Related]
11. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice.
Fowler DH; Kurasawa K; Smith R; Eckhaus MA; Gress RE
Blood; 1994 Nov; 84(10):3540-9. PubMed ID: 7949109
[TBL] [Abstract][Full Text] [Related]
12. The role of CD4+ and CD8+ cells in normal F1 hybrid host in the resistance to lethal graft-versus-host disease induction by transfer of parent spleen cells.
Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
Immunol Lett; 1994 Jun; 40(3):207-10. PubMed ID: 7959888
[TBL] [Abstract][Full Text] [Related]
13. CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy.
Morecki S; Gelfand Y; Yacovlev E; Eizik O; Shabat Y; Slavin S
Biol Blood Marrow Transplant; 2008 Sep; 14(9):973-984. PubMed ID: 18721760
[TBL] [Abstract][Full Text] [Related]
14. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
[TBL] [Abstract][Full Text] [Related]
15. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
Zhang Y; Hexner E; Frank D; Emerson SG
J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
[TBL] [Abstract][Full Text] [Related]
17. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
18. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
[TBL] [Abstract][Full Text] [Related]
19. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
[TBL] [Abstract][Full Text] [Related]
20. Expansion of intermediate T-cell receptor cells in mice with autoimmune-like graft-versus-host disease.
Ikarashi Y; Abo T; Kawai K; IIai T; Watanabe H; Suzuki K; Matsumoto Y; Omata S; Fujiwara M
Immunology; 1994 Oct; 83(2):205-12. PubMed ID: 7835936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]